Breaking News

ADC Market Predicted to Grow to $4B

A new analysis in the CPhI Annual Report estimates the increase in growth by 2023

The global ADC therapeutics market is expected to grow to $4B by 2023, with double digit approvals within 3-years, according to a new analysis in the CPhI Annual Report.   Vivek Sharma, chief executive officer of Piramal Pharma Solutions, expects the global market for ADCs to grow at around 19% CAGR between 2017 and 2030 and reach an estimated value of $4 billion in the next five years, with 17 drugs that are either approved or in late stages of clinical development, catalyzing such growth.  ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters